The Faculty of Business invites members of the campus community – students, faculty and staff – to attend a virtual research presentation by Dr. Reuben Domike for a tenure-track position at the assistant professor level with a focus on entrepreneurship.

Candidate Bio:

Dr. Reuben Domike is a Teaching Professor of Technology and Information Management (T.I.M.) at the University of California Santa Cruz (UCSC). He specializes in entrepreneurship/innovation. He holds a PhD in Chemical Engineering Practice (joint engineering and management) from the Massachusetts Institute of Technology (MIT) awarded in 2004 and an MBA from the Sloan School of Management at MIT. Prior to joining UCSC, he was an associate professor at the Brigham Young University and an associate professor at the University of Prince Edward Island (UPEI) in the Faculty of Business where he was the founding director of the university-wide Hostetter Centre for Enterprise and Entrepreneurship. Prior to joining UPEI in 2009, Dr. Domike was the founding director of a university-wide Center for Entrepreneurship at the College of Wooster in Ohio (funded by the Ewing Marion Kauffman Foundation).

Over the past twenty years, Dr. Domike has been involved in developing start-up companies in the areas of software; management consulting; industrial water filters; and essential oil extraction. Four of these companies (two on PEI) are now significant with millions of dollars in revenue and dozens of employees each. On PEI, he has worked with dozens of small businesses and aspiring entrepreneurs to advance their plans and operations. His current research activities are primarily in collaboration with the US Food and Drug Administration (FDA) and the Center for Biomedical Innovation (CBI) in the MIT Engineering Systems Division, focused on quantitative assessment of new technologies in pharmaceutical products and manufacturing.

Abstract:

“Dr. Domike recently led a workshop on risk assessment for technology innovation in biomanufacturing. The workshop involved thirty-one colleagues from industry representing nineteen different biopharmaceutical companies (including Pfizer, Amgen, Biogen, Merck) engaged through MIT's Center for Biomedical Innovation.  The workshop was focused on identifying, quantifying, and mitigating risks associated with operating both human and non-human host cell systems in an open manufacturing facility.

The quality risk management (QRM) approach utilized in the workshop aligned with that of the International Council for Harmonisation. It also built upon prior research publications authored by Dr. Domike focused on practically implementing QRM consistent with the FDA’s 21st-century quality initiative. The workflow that was designed and enacted was aligned with best practices in innovation utilized for risky endeavours in high-technology industries (e.g., aerospace, automobile automation). The workflow utilized mapping the manufacturing process, defining the risk question, risk evaluation, and risk control. The workshop outcomes included a completed failure mode and effects analysis that can be used as a guideline during practical implementation of the technology innovation. 

These approaches to QRM and innovation management are relevant to bio-tech companies on PEI, and Dr. Domike has enacted these approaches in some of those PEI companies.

The research presentation will take place on Wednesday, March 9, from 12:45 to 2 pm.

https://upei.zoom.us/j/61549675658?pwd=cXFKdXQ0UlJ6RGxoK1Flb21vamZ1QT09

Meeting ID: 615 4967 5658

Passcode: 294555

For further information, please contact Shelly Kavanagh at businessfac@upei.ca.